Topic:"Regulatory Approval Processes" in M11630

Table 4: Update on Implementation of 2022 Verification Recommendations Year Evaluation/ Verification Recommendation Text Source Status Comments Expected Period of Completion

AI summary The table outlines the status of implementing recommendations from the 2022 verification process. It includes details such as the year, evaluation/verification, recommendation text, source, status, comments, and expected period of completion for each recommendation.

1.2 Follow-up on Past Evaluation Report Recommendations The Evaluator issued improvement recommendations in previous years. No major recommendations were made in 2022, and only one recommendation from 2018 remains under review. [Table](#pa...

AI summary The Evaluator provided improvement recommendations in previous years, with no major recommendations in 2022. Only one 2018 recommendation remains under review, and Table 5 summarizes its implementation status.

Rationale for Using an Equivalent EUL The LED market is evolving rapidly, driven in part by government regulations. LED products installed today are likely to become the baseline before the end of their rated lifetime since LED technologie...

AI summary The document discusses the rationale for using an equivalent EUL (Energy Use Lifetime) for LED lighting products, noting that rapid technological advancements and falling prices mean current LED products may become the baseline before their rated lifetime ends. It highlights U.S. and Canadian regulatory developments, including the EISA backstop and upcoming changes to lighting standards, which are expected to shift the baseline for LED lamps in 2025.

M11630 / 2023 DSM Annual Progress Report, 2023 DSM Evaluation Reports, 2023 Savings Verification Report // EfficiencyOne Reply to Stakeholder Comments DSMAG Member Comments E1 Response

AI summary The document outlines the EfficiencyOne response to stakeholder comments on the 2023 DSM Annual Progress Report, Evaluation Reports, and Savings Verification Report. It reflects engagement with the DSM Advisory Group and other stakeholders in the regulatory process.